NATIONAL CANCER RESEARCH INSTITUTE
The advancement of health, in particular to promote and protect the health of the public by coordinating research into the causes, prevention, treatment and cure of all forms of cancer and into the needs of people affected by cancer. And to promote collaboration between cancer research funders in the UK to maximise the value and benefits of cancer research for the benefit of the public.
Financial health, per its FY2022 accounts
The accounts state that total income for the year was £1.6m, while total expenditure was £1.8m, resulting in a net deficit of £194,340. Per the trustees' report, unrestricted reserves stood at £970,651, which is in excess of the stated policy target range of £554,000–£692,000.
What the accounts disclose
“NCRI’s Partner membership remains the primary source of income. Breakdown of underlying income £1.6m Membership Contribution 78%” — page 24
Structured financials (annual return, FY ending 31/03/2022)
Register events
- Transferred assets to another charity (14/08/2026)
- Transferred assets to another charity (14/08/2026)
- Transferred assets to another charity (14/08/2026)
- Transferred assets to another charity (14/08/2026)
- Transferred assets to another charity (14/08/2026)
- Transferred assets to another charity (14/08/2026)
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | — | — |
| 31/03/2024 | — | — |
| 31/03/2023 | — | — |
| 31/03/2022 | £1.6m | £1.8m |
| 31/03/2021 | £1.5m | £1.8m |
Common questions
Is NATIONAL CANCER RESEARCH INSTITUTE financially healthy?
Per its FY2022 accounts: The accounts state that total income for the year was £1.6m, while total expenditure was £1.8m, resulting in a net deficit of £194,340. Per the trustees' report, unrestricted reserves stood at £970,651, which is in excess of the stated policy target range of £554,000–£692,000. Its FY2022 accounts were audited by Sayer Vincent LLP.
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| DAVID LISTER CHARITABLE TRUST | 3 | £154k |
| MILLS AND REEVE CHARITABLE TRUST | 3 | £10k |
| THE MASTER CHARITABLE TRUST | 2 | £1.5m |
| THE PENNIES FOUNDATION | 2 | £395k |
| PEACOCK CHARITABLE TRUST | 2 | £265k |
| THE GEORGE CADBURY TRUST (GEORGE HENRY T AND LAURENCE J CADBURY SECTIONS) | 2 | £94k |
| SANDRA CHARITABLE TRUST | 2 | £47k |
| INCORPORATED CHURCH INSTITUTE, UPPER TOOTING | 2 | £21k |
Charities like this
- CANCER RESEARCH WALES
- CANCER RESEARCH UK
- THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY
- CANCER RESEARCH AND GENETICS UK
- THE CANCER TREATMENT AND RESEARCH TRUST CIO
- YORKSHIRE CANCER RESEARCH
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| NATIONAL CANCER RESEARCH INSTITUTE | £1.6m | — | — | above | — | no doubt |
| CANCER RESEARCH WALES | £5.9m | — | — | unclear | — | no doubt |
| CANCER RESEARCH UK | £734.8m | — | 380 | above | 22.0% | no doubt |
| THE INSTITUTE FOR CANCER VACCINES AND IMMUNOTHERAPY | £433k | £70,001 - £80,000 | 1 | unclear | 6.0% | no doubt |
| CANCER RESEARCH AND GENETICS UK | £128k | — | 0 | unclear | — | no doubt |
| THE CANCER TREATMENT AND RESEARCH TRUST CIO | £502k | — | 0 | above | — | no doubt |